Why I think $MBOT is the most undervalued, overlooked, multi-bagger around.

Here is my DD on Microbot Medical and why I think it’s a sleeping giant. $MBOT current price: $2.10 ✨ What is Microbot Medical Inc ($MBOT) ? * Focus: Developing and commercializing robotic-assisted medical technologies for minimally invasive procedures, including endovascular interventions. * Key Technology: The LIBERTY System (FDA cleared a few months ago), is a remotely operated, single-use robotic platform for precise, efficient, and safer procedures. A few weeks ago they launched a limited release of LIBERTY, which has since been adopted by and is now used by different healthcare providers around the country. * Platforms: Also utilizes ViRob (crawling micro-robot) and TipCAT technologies. _____ ✨New 2026 Milestones Built on 2025 Wins Just yesterday, Microbot issued a company update highlighting its 2025 operational achievements and outlining 2026 growth catalysts, including: 🔹 Full Market Release of LIBERTY scheduled for Q2 2026 🔹 Expansion into more hospitals and procedure types 🔹 Strategic partnerships, teleintervention trials, and global commercialization plans 🔹 A growing intellectual property portfolio with 20 patents granted and 52 pending 🔹 A targeted U.S. market of 2.5 million peripheral endovascular procedures annually 🔹 Strong clinical data: 100% robotic navigation success and 92% reduction in radiation exposure reported from pivotal trial data shared at major medical meetings 🔹 Early adopter momentum and customer feedback building commercial confidence. _____ ✨ Liberty System is Now FDA-Cleared and Selling Microbot successfully achieved FDA 510(k) clearance for its flagship LIBERTY Endovascular Robotic System — a major regulatory milestone that unlocks commercialization in the U.S. market. ⸻ ✨ Strong Support ✔️ A non-dilutive grant strengthened manufacturing readiness without diluting shareholders. ✔️ The stock is now garnering broader index visibility, adding to the potential investor base. _____ ✨ SUMMARY 🚀 FDA clearance → commercial release 🚀 Early adopter hospitals → growing pipeline 🚀 Capital raised → commercialization runway secured 🚀 Clear 2026 milestones → measurable catalysts